QuidelOrtho Corp (QDEL)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch QDEL
See up to 3 months of QDEL. The 7-day demo opens the 1M and 3M ranges and puts QDEL on your watchlist.
Start 7-day demoLatest QDEL insider trades
About QuidelOrtho Corp (QDEL)
QuidelOrtho Corp is an SEC registrant, filing under CIK 0001906324, classified as in vitro and in vivo diagnostic substances. We track it alongside the rest of the Health Care sector.
QDEL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 4 | 6,024 | |
| Tax withholding / forfeiture | 2 | 1,083 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
QDEL insider transactions (Form 4)
7786 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ronald Lee Bowman - Officer | Option exercise | Common Stock | 2,566 footnote F1 | $0.00 | - | |
| Ronald Lee Bowman - Officer | Tax withholding / forfeiture | Common Stock | 921 footnote F2 | $10.63 | $10K | |
| Ronald Lee Bowman - Officer | Option exercise | Restricted Stock Units | 2,566 | $0.00 | - | |
| ||||||
 Bryan Michael Hanson - Officer | Option exercise | Common Stock | 446 footnote F1 | $0.00 | - | |
| Bryan Michael Hanson - Officer | Tax withholding / forfeiture | Common Stock | 162 footnote F2 | $14.30 | $2K | |
| Bryan Michael Hanson - Officer | Option exercise | Restricted Stock Units | 446 | $0.00 | - | |
| ||||||
 Micah W. Young - Officer | Grant or award | Restricted Stock Units | 356,555 | $0.00 | - | |
| Bryan Michael Hanson - Officer | Option exercise | Common Stock | 5,797 footnote F1 | $0.00 | - | |
| Bryan Michael Hanson - Officer | Tax withholding / forfeiture | Common Stock | 2,096 footnote F2 | $18.18 | $38K | |
| Bryan Michael Hanson - Officer | Option exercise | Restricted Stock Units | 5,797 | $0.00 | - | |
| ||||||
| Kenneth J. Widder - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Kenneth J. Widder - Director | Grant or award | Restricted Stock Units (Converted) | 6,656 | $0.00 | - | |
| Kenneth J. Widder - Director | Grant or award | Restricted Stock Units (Premium) | 1,997 | $0.00 | - | |
| R. Scott Huennekens - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| John R. Chiminski - Director | Grant or award | Restricted Stock Units (Converted) | 5,547 | $0.00 | - | |
| John R. Chiminski - Director | Grant or award | Restricted Stock Units (Premium) | 1,109 | $0.00 | - | |
| John R. Chiminski - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Joseph D. Wilkins Jr. - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
 Ann D. Rhoads - Director | Grant or award | Restricted Stock Units (Premium) | 369 | $0.00 | - | |
| Ann D. Rhoads - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Ann D. Rhoads - Director | Grant or award | Restricted Stock Units (Converted) | 3,698 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Grant or award | Restricted Stock Units (Premium) | 1,664 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Grant or award | Restricted Stock Units (Converted) | 5,547 | $0.00 | - | |
| Edward L. Michael - Director | Grant or award | Restricted Stock Units (Premium) | 1,053 | $0.00 | - | |
| Edward L. Michael - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Edward L. Michael - Director | Grant or award | Restricted Stock Units (Converted) | 3,513 | $0.00 | - | |
 Evelyn S. Dilsaver - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
 Kenneth F. Buechler - Director | Grant or award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | - | |
| Kenneth F. Buechler - Director | Grant or award | Restricted Stock Units (Converted) | 12,204 | $0.00 | - | |
| Kenneth F. Buechler - Director | Grant or award | Restricted Stock Units (Premium) | 3,661 | $0.00 | - | |
| Kenneth J. Widder - Director | Grant or award | Common Stock | 910 footnote F1 | $0.00 | - | |
| Kenneth J. Widder - Director | Grant or award | Common Stock | 273 footnote F1 | $0.00 | - | |
| Kenneth J. Widder - Director | Option exercise | Restricted Stock Units (Converted) | 910 | $0.00 | - | |
| Kenneth J. Widder - Director | Option exercise | Restricted Stock Units (Premium) | 273 | $0.00 | - | |
| ||||||
| Mary Lake Ph D. Polan - Director | Grant or award | Common Stock | 749 footnote F1 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Grant or award | Common Stock | 224 footnote F1 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Option exercise | Restricted Stock Units (Converted) | 749 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Option exercise | Restricted Stock Units (Premium) | 224 | $0.00 | - | |
| ||||||
| Kenneth F. Buechler - Director | Grant or award | Common Stock | 1,659 footnote F1 | $0.00 | - | |
| Kenneth F. Buechler - Director | Grant or award | Common Stock | 497 footnote F1 | $0.00 | - | |
| Kenneth F. Buechler - Director | Option exercise | Restricted Stock Units (Converted) | 1,659 | $0.00 | - | |
| Kenneth F. Buechler - Director | Option exercise | Restricted Stock Units (Premium) | 497 | $0.00 | - | |
| ||||||
| Edward L. Michael - Director | Grant or award | Common Stock | 963 footnote F1 | $0.00 | - | |
| Edward L. Michael - Director | Grant or award | Common Stock | 289 footnote F1 | $0.00 | - | |
| Edward L. Michael - Director | Option exercise | Restricted Stock Units (Converted) | 963 | $0.00 | - | |
| Edward L. Michael - Director | Option exercise | Restricted Stock Units (Premium) | 289 | $0.00 | - | |
| ||||||
| Matthew Strobeck - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Matthew Strobeck - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Kenneth J. Widder - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Kenneth J. Widder - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Mary Lake Ph D. Polan - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Mary Lake Ph D. Polan - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Kenneth F. Buechler - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Kenneth F. Buechler - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| John R. Chiminski - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| John R. Chiminski - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| R. Scott Huennekens - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| R. Scott Huennekens - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Joseph D. Wilkins Jr. - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Joseph D. Wilkins Jr. - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Ann D. Rhoads - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Ann D. Rhoads - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Edward L. Michael - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Edward L. Michael - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Evelyn S. Dilsaver - Director | Grant or award | Common Stock | 6,829 footnote F1 | $0.00 | - | |
| Evelyn S. Dilsaver - Director | Option exercise | Restricted Stock Units (Equity Grant) | 6,829 | $0.00 | - | |
| ||||||
| Ann D. Rhoads - Director | Grant or award | Common Stock | 1,173 footnote F1 | $0.00 | - | |
| Ann D. Rhoads - Director | Option exercise | Restricted Stock Units (Converted) | 1,173 | $0.00 | - | |
| Ann D. Rhoads - Director | Option exercise | Restricted Stock Units (Premium) | 234 | $0.00 | - | |
| Ann D. Rhoads - Director | Grant or award | Common Stock | 234 footnote F1 | $0.00 | - | |
| ||||||
| Brian J. Blaser - Officer | Grant or award | Common Stock | 20,759 footnote F1 | $0.00 | - | |
| Brian J. Blaser - Officer | Tax withholding / forfeiture | Common Stock | 10,252 footnote F2 | $10.32 | $106K | |
| Brian J. Blaser - Officer | Option exercise | Restricted Stock Units | 20,759 | $0.00 | - | |
| ||||||
| Bryan Michael Hanson - Officer | Grant or award | Common Stock | 1,459 footnote F1 | $0.00 | - | |
| Bryan Michael Hanson - Officer | Tax withholding / forfeiture | Common Stock | 528 footnote F2 | $11.59 | $6K | |
| Bryan Michael Hanson - Officer | Option exercise | Restricted Stock Units | 1,459 | $0.00 | - | |
| ||||||
Item 1.01, 9.01
Item 2.02, 9.01
Item 5.02, 7.01, 9.01
Item 5.07
QDEL insider trading FAQ
What is the latest insider trade for QDEL?
QuidelOrtho Corp (QDEL) had 2 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for QDEL runs to 86 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QDEL stock?
No insider purchases of QDEL were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling QDEL stock?
No insider sales of QDEL were filed in the last 90 days. 2 sales are on record for this company.
Where can I see QDEL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QDEL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ronald Lee Bowman view on EDGAR
- - Bryan Michael Hanson view on EDGAR
- - Micah W. Young view on EDGAR
- - Bryan Michael Hanson view on EDGAR
- - Kenneth J. Widder view on EDGAR
- - R. Scott Huennekens view on EDGAR
- - John R. Chiminski view on EDGAR
- - Joseph D. Wilkins Jr. view on EDGAR
- - Ann D. Rhoads view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where QDEL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QDEL with a 7-day demo
- QDEL on your watchlist
- Every QDEL Form 4 filing on record
- Up to 3 months of QDEL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
